The RESI (Redefining Early Stage Investments) kicks off today in Boston, Massachusetts, where 200 early stage investors, 300 fundraising executives and 100 service providers will meet for a one-day international partnering meeting that gives early stage life science companies the chance to book target meetings with relevant investors.
RESI Conference activities include the RESI Innovation Challenge, where attendees will use RESI cash tokens to “invest” in the conference’s most compelling RESI Innovators. The invested capital will be tallied and the Top 3 winners will receive an award at a cocktail reception at the end of the day.
Investor panels will cover a wide range of topics, including biotech angels to preclinical and phase I investors, phase II and III investors, big pharma, corporate venture capital, NIH funding and resources for startups, medical device investors, and more.
The vast lineup of early stage entrepreneur workshops include topics ranging from fundraising boot camp and government grants and contracts, to branding and messaging and how to research global investors.
The RESI Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. Following highly successful events in San Francisco and Houston, earlier this year, the 2015 RESI conference in Boston is expected to be the biggest yet.
Upcoming RESI Conference schedules include San Francisco in January 2016, Houston in April, Toronto in June, and Boston again next September.
For more information, visit www.resiconference.com
